Endometrial cancer is the most common gynecological malignancy, with 41,000 new cases
projected in the United States for 2006. Two different clinicopathologic subtypes are …

In the Western world, endometrial carcinoma is the most common malignant tumour of the
female genital tract and the fourth most common cancer in women after carcinomas of …

In the western world, endometrial carcinoma (EC) is the most common cancer of the female
genital tract. The annual incidence has been estimated at 10–20 per 100 000 women. Two …

Two types of endometrial carcinoma are distinguished with respect to biology and clinical
course. Type-I carcinoma is related to hyperestrogenism by association with endometrial …

Molecular profiling of endometrial neoplasms reveals genetic changes in endometrial
carcinomas that support the dualistic model, in which type I carcinomas are estrogen …

On a clinicopathological and molecular level, two distinctive types of endometrial carcinoma,
type I and type II, can be distinguished. Endometrioid carcinoma, the typical type I …

Most sporadic endometrial cancers (ECs) can be histologically classified as endometrioid,
serous, or clear cell. Each histotype has a distinct natural history, clinical behavior, and …

In 1983, Bokhman proposed a dualistic model of endometrial tumorigenesis based on the
clinical observations and clinicopathologic correlations. The majority of endometrial cancers …

Background Understanding and identifying molecular biology and genetics of endometrial
cancer are central to the development of novel therapies. This article reviews the molecular …

Endometrial cancer is the most commonly diagnosed gynecologic malignancy in the United
States. Endometrioid endometrial carcinomas constitute approximately 85% of newly …